Myelodysplastic Syndromes

Watchlist

(log in to enable)

Retrieved

2023-08-16

Source

Mayo_clinic

Trials

—

Genes

SF3B1, ASXL1, GATA2, U2AF1, TET2, SBDS, ZRSR2, SETBP1, MPL, PTPN11, SRSF2, RUNX1, FANCB, TP53, ATRX, RAD51, XRCC2, CALR, BRCA2, ERCC4, FANCD2, SH2B3, UBE2T, MECOM, CDKN2B, RAD51C, CEBPA, CSF3R, CBL, MAD2L2, CSF1R, BRCA1, FANCG, FANCF, EPO, SLX4, BRIP1, PALB2, GATA1, FANCE, FANCM, FANCC, FANCA, FANCI, FANCL, EZH2, PLCB1, HFE, BMI1, MYC, DLK1, KRAS, SAMD9, DAPK1, CUX1, CTNNA1, TLR2, ARHGAP26, CFLAR, ACSL6, LYL1, STAG2, HDAC1, CTC1, SPHK1, SMPD3, BLM, IDH1, IDH2, JAK2, NRAS, KIT, DNMT3A, RPS14, THPO, DDX41, GFI1, PIGA, RPS19, TERC, HRAS, TERT, GFI1B, SRP72, ELANE, LIG4, NUP98, CDKN2A, IRF1, SRP54, KMT2A, SMARCD2, IL6, CSF2, RFWD3, CCR7, RAF1, TINF2, TRNL1, DKC1, CD274, ABCB1, NPM1, CSF3, BRAF, GSTT1, NBEAL2, EFL1, BUB3, TRIP13, RECQL4, CD33, DNAJC21, CD34, CEP57, GNB1, GINS1, CD38, WT1, SF3B2, TCIRG1, HAX1, NAGS, VEGFA, ABL1, BUB1B, BCR, BCL2, TNF, ETV6, BUB1, FLT3, SGCE, BCOR, STAT3, S100A9, SCT, GSTM1, HOXD13, HTC2, RARS1, DNMT1, SCN4A, RN7SL263P, KITLG, MLF1, DERL1, WNT1, IL3, INTS1, MAPK1, TGFB1, TBC1D9, HOXA9, HPGDS, CTNNB1, AADAC, PAFAH1B1, CD14, TRBV20OR9-2, TNFSF10, PRDM16, CHEK2, FBXW4, NLRP3, SLCO6A1, YWHAE, GSTK1, FAS, MIR21, IL1B, SLU7, CXCL8, AIMP2, GRAP2, MRPL28, H3P9, SOCS1, SUB1, ISG20, THY1, TFRC, SALL4, RNF19A, POLDIP2, HSPA9, AHSA1, PTEN, NXT1, IFNG, IL2RA, MVD, MMP9, SPARC, H3P10, CD6, EGR1, CRK, CD59, MAPK14, CCND1, CDA, E2F1, ATM, BCL2L10, WT1-AS, MIR222, MIR22, CSNK1A1, CD36, DICER1, CASP3, HLA-DRB1, MIR155, RARA, PLCG1, MECP2, DCC, MDM2, CDKN1C, MIR143, PRAME, PTPRC, PIK3CA, U2AF1L5, NQO1, BCORL1, NCAM1, PSMG2, HIF1A, CALCA, MGMT, RPL22, CD55, QRSL1, TLR4, S100A8, RBM45, PIK3CG, IL17A, DLL1, IGHV1-12, DDIT3, IL10, HOXA@, IL3RA, ACTB, CXCL12, RAG1, POGLUT1, IGF1, PTPN6, SPN, KIR3DL1, ATN1, MIR145, CRBN, MIR146A, FOXP3, ITGA2B, HAMP, PARP1, MAPK3, PIK3CB, PIK3CD, GEM, NF1, PROM1, FUT4, HAVCR2, MBD2, RUNX1T1, AURKB, RUNX2, MPO, FHIT, AKT1, FECH, FCGR3B, FCGR3A, EPOR, MYD88, ERCC2, DOCK4, PHF6, MYBL2, MYB, MME, IER3, ANPEP, KDM6A, OGG1, CXCR4, PDCD1, XRCC1, GZMB, GYPA, ENPEP, HBA1, HBA2, CD99, RB1, CTLA4, BBX, ATG3, RAP1GAP, MXI1, CSF1, MYH11, BRCC3, BAALC, RAC1, NEDD8, MAPK8, ANGPT1, CREBBP, NOTCH1, CTAG1B, RING1, KMT2C, PDCD1LG2, NM, INTS2, PSMD9, ANGPT2, PMAIP1, ARHGAP24, PLK1, ORC5, PURA, AURKA, LAMTOR1, HMGA2, PPM1D, NR0B2, AKAP13, ANKRD26, CDR3, KDM6B, NUP214, CHGB, MAFK, DEK, SIRT1, XIST, BRD4, WAS, MLLT11, RIPK1, DCTN6, NR1I2, VPS51, ZNRD2, ATG7, CIB1, RPL23, EEF1E1, SPAG6, IKZF1, AKAP12, TRIB1, CASP1, GDF11, ZNF197, CD47, UBE2I, TWIST1, SOX7, APC, APEX1, ABAT, LUC7L2, CFL1, GDE1, IL23A, CXXC5, ATRAID, SOAT1, SLC25A37, CDKN2C, STAT1, PLCE1, LEF1, ATR, TMED7, CDKN1B, TEK, CDKN1A, CDC25C, TGFBR1, HIPK2, TRIB2, TIMP1, TIMP2, CD69, TP73, TPO, TRAF6, MUC1, SEMG1, NSD1, ADA, GNAS, GLI1, PGP, RGPD2, CTAG1A, ITGB3, SAMD9L, DCK, CLEC12A, MCL1, PDIK1L, LGALS9, XRCC6, LIF, G6PD, FUT1, MAD2L1, TPPP2, GOT1, IL18, GPX3, TICAM2, HLA-DPB1, HLA-A, AGFG2, MIR34A, HSPA4, MIR134, ID4, MIR125B1, IFI27, MIR125A, IGF1R, H2AX, EIF4E, GSTP1, MIR378A, IL2, DDX10, SMAD7, HMOX1, ABCB7, FLT1, FTMT, MSH2, PSC, MNDA, COMMD3-BMI1, ETFA, H3P23, MET, MMP2, G6PC3, FLT3LG, MEFV, TMED7-TICAM2, ERCC6, H3P12, FGF3, LINC02605, AZGP1, PART1, MIR99B, PRPF40B, ZFPM2, CADM1, CAPN1, BAAT, CLEC5A, ABO, AMACR, PIGN, SF3A1, MIR17HG, UBL7-AS1, MIR196B, CABIN1, SUZ12, MTCO2P12, PRPF8, SIN3A, STUB1, MIR28, MIR29A, DNM1L, ARG1, NAAA, DKK3, MIR29B1, MIR29B2, BBC3, FOXP1, DNAI1, SLC17A5, EBI3, STS, MIR30A, FBXL5, MIR30D, MIR320A, WIPI2, H3P13, MIR34B, AXL, L3MBTL1, TIFAB, MIR93, MIR424, BCHE, CRTC1, USP24, RIPK3, MIR4485, GLIPR1, BMP2, RAB40B, PSS, BMP4, KLRC4-KLRK1, HPSE, SEPTIN9, ZMYND11, TEC, MIR874, PLK2, NES, BNIP3L, PLK4, EBP, ALL1, CACNA1A, SPINT2, COLEC10, MIR1275, PDLIM5, BTK, PIM2, MIR671, CIB2, MIR661, MIR451A, ANKRD28, LEF1-AS1, BDH1, TLR6, SFTPA1, BDNF, SEMA3A, MIR595, MIR636, ECI2, BIK, DIDO1, PLA2R1, KLRK1, CAMP, U2AF2, MIR4725, PARK7, POTEF, BLVRB, MIR223, PSIP1, MIR4462, RASSF1, FSD1L, MIR221, HJV, MSI2, CAST, ANG, UHMK1, TSHZ2, JAG1, HPSE2, ZNF410, LSM2, SGCZ, A2ML1, PRIMA1, PWAR1, TRIB3, CIP2A, MIR210, ERFE, RALGAPB, CD177, PCBP4, SLC12A9, ACVR2A, CHPT1, HBFQTL4, MLKL, MFF, TCIM, CCL28, CFC1, ZBTB38, FGD4, GORASP1, WNK1, SP7, ALAS2, MAGT1, USP42, MAML2, SYVN1, CHST9, GLIS2, MAP1LC3B, KDM2B, CCDC54, CXXC4, ALK, PANK2, ATAD1, DHDDS, UBASH3B, ALOX5, ZMAT4, USB1, GFM1, ALPI, DERL3, SLC52A2, FSD1, AHSG, MYSM1, ALPP, MPPE1, FRTS1, MDS2, HDAC8, PAG1, MIR10A, BIRC3, POMP, MIR10B, ZMYND10, CDC40, MIR124-3, TLR7, MIR126, CDKL3, GP6, MIR144, MIR150, IRAK4, XIAP, MIR15A, UCK1, RRM2B, SEC61A1, ICOS, MIR195, MIR20A, BIRC5, PYCARD, FASLG, MIR205, DROSHA, ACHE, AR, SETD2, DCDC2, MIRLET7B, AP5M1, MIRLET7A3, CHFR, ATF7IP, FRYL, ILDR1, SAGE1, TSPAN33, ASXL2, ANXA2, ANXA5, APAF1, MARCHF1, COL6A4P1, ARSH, RBMY2DP, NSD3, BIRC2, KRT20, RIN2, NANS, TLR9, SPA17, RTEL1, RBMY1D, ACSL5, HOXB-AS3, NBAS, LINC01194, TRIM33, PIAS4, MIR17, ETV1, PDCD6, LRP1, MARCKS, MXD1, SMAD5, MCM2, MEIS1, DAB2, MIF, CYP3A5, MLH1, CYP3A4, MLLT1, MLLT3, MMP1, CYP2E1, MMP14, CD200, CYP2B6, LTA, DAP, MSH3, LEPR, GADD45A, ACE, ITGA4, ITGAM, ITGB4, ITIH4, JAK1, JAK3, JARID2, KDR, KIR2DL1, KIR2DL3, DAPK3, LAG3, STMN1, LDLR, LEP, MPV17, MST1, MVP, NR4A2, P2RX7, PAK1, PCM1, PCNA, PDE4A, PDGFRB, PGK1, PIP4K2A, PLA2G4A, PLCB4, POMC, PTPA, PPP3CA, PRB1, PRKCA, EIF2AK2, PRSS1, OPRK1, CTBP1, MT1E, NOS2, COX1, COX2, MTHFR, MTTP, CYP1B1, CYBA, MYT1, NAGLU, NBN, SEPTIN2, NFE2L2, NFKB1, NGF, NME1, NME4, NOP2, NOS1, IRAK1, INPP5D, CXCL10, SLC29A1, GGT1, GH1, ENG, GP9, GPI, GPT, GRB2, PDIA3, GSK3A, GSK3B, ENDOG, GYPB, GYPE, GYS1, HAS2, HBG1, HBG2, GFAP, EP300, IL15, GABPA, EVPL, F2R, F9, ESR1, ERG, ERCC1, EPHB2, FGF1, FHL2, FOXM1, FOXO1, FOXO3, FLI1, FLII, EPHA3, FOS, FRZB, HCK, EGF, HGF, HIC1, IAPP, ICAM1, SARDH, DLX4, IFIT1, IFNA2, DIO3, IGF2, IGFBP3, IGH, IGHG3, IL1A, DIAPH1, DECR1, IL7, CXCR2, IL13, HTR1B, DUSP1, HES1, HNRNPA1, HLA-B, HLA-C, HLA-E, HMGB1, HMGA1, NR4A1, SLC29A2, HNRNPD, PRMT1, HNRNPK, EBF1, HOXA11, HOXA13, HOXB@, HP, TOR1A, PSMA7, PSMB6, PTCH1, XRCC3, ETS1, YWHAB, ZNF140, ZBTB17, MAP3K12, PRDM2, CD28, GPR68, TCL1A, SLC7A5, CMS1A1, CD22, USP9X, BAP1, EOMES, FZD9, MS4A1, XRCC5, CD40, TP53BP1, XPA, TRAF2, TRI-AAT9-1, TRP-AGG2-5, TRPC1, TTR, TNFRSF4, TYRP1, CD48, UBE2N, NR1H2, UROD, UROS, USF2, VHL, CD44, WRN, CD40LG, MAD1L1, KLF11, CNTNAP1, IKBKG, PKMYT1, MYOM2, IL32, MSC, CRLF1, SRSF11, CASP8, CASP5, ABCG2, GDF15, APOBEC3B, ESPL1, HDAC9, TM9SF4, KEAP1, ELMO1, GAB2, PIAS2, PRC1, CBFB, EED, YBX3, PDLIM4, TP63, NUMB, CD19, IRS2, STX11, FADD, MCM3AP, CD247, TNFRSF10C, TNFRSF10B, TNFRSF10A, IL18R1, CCNH, CCND3, TPMT, TOP2A, CREB1, ROS1, RPL27A, CCR6, CHRM4, RRM2, SAA1, SAA2, TSPAN31, CHEK1, SCN7A, CEACAM8, SRL, CCL2, CCL20, SELE, SFRP1, SFRP4, SFRP5, RPA3, ROBO2, TNFRSF1B, ROBO1, PTK2, CRAT, PTPN13, PURB, CPT2, CPT1A, RAD52, COX8A, RANBP2, RAP1A, RAP1B, COL4A2, RBMY1A1, OPN1LW, REG1A, RELA, RIT1, CEBPE, SIPA1, SKI, SLC19A1, TDG, PRDX2, CDK2, TFR2, CDH1, TGFBI, TGFBR2, THBD, THBS1, CDC20, TIA1, TIE1, TK1, TK2, TLR1, CD68, TNFRSF1A, PPP1R11, TCF21, TCF4, SPP1, SLC22A5, SMARCA1, HLTF, SMARCB1, CD52, SOD2, CDKN3, SRF, TBCC, CDKN2D, STAT5A, STAT5B, STK4, STK11, SYK, SYT1, YY1

Drugs

—

Interested in hearing about new therapies?

Overview

Myelodysplastic syndromes are a group of disorders caused by blood cells that are poorly formed or don't work properly. Myelodysplastic syndromes result from something amiss in the spongy material inside your bones where blood cells are made (bone marrow).

Management of myelodysplastic syndromes is most often intended to slow the disease, ease symptoms and prevent complications. Common measures include blood transfusions and medications to boost blood cell production. In certain situations, a bone marrow transplant, also known as a stem cell transplant, may be recommended to replace your bone marrow with healthy bone marrow from a donor.

Symptoms

People with myelodysplastic syndromes might not experience signs and symptoms at first.

In time, myelodysplastic syndromes might cause:

Fatigue
Shortness of breath
Unusual paleness (pallor), which occurs due to a low red blood cell count (anemia)
Easy or unusual bruising or bleeding, which occurs due to a low blood platelet count (thrombocytopenia)
Pinpoint-sized red spots just beneath the skin that are caused by bleeding (petechiae)
Frequent infections, which occur due to a low white blood cell count (leukopenia)

When to see a doctor

Make an appointment with your doctor if you have signs or symptoms that worry you.

Causes

In a healthy person, bone marrow makes new, immature blood cells that mature over time. Myelodysplastic syndromes occur when something disrupts this process so that the blood cells don't mature.

Instead of developing normally, the blood cells die in the bone marrow or just after entering the bloodstream. Over time, there are more immature, defective cells than healthy ones, leading to problems such as fatigue caused by too few healthy red blood cells (anemia), infections caused by too few healthy white blood cells (leukopenia) and bleeding caused by too few blood-clotting platelets (thrombocytopenia).

Most myelodysplastic syndromes have no known cause. Others are caused by exposure to cancer treatments, such as chemotherapy and radiation, or to toxic chemicals, such as benzene.

Types of myelodysplastic syndromes

The World Health Organization divides myelodysplastic syndromes into subtypes based on the type of blood cells — red cells, white cells and platelets — involved.

Myelodysplastic syndrome subtypes include:

Myelodysplastic syndromes with single-lineage dysplasia. One blood cell type — white blood cells, red blood cells or platelets — is low in number and appears abnormal under the microscope.
Myelodysplastic syndromes with multilineage dysplasia. In this subtype, two or three blood cell types are abnormal.
Myelodysplastic syndromes with ring sideroblasts. This subtype involves a low number of one or more blood cell types. A characteristic feature is that existing red blood cells in the bone marrow contain rings of excess iron.
Myelodysplastic syndromes with isolated del(5q) chromosome abnormality. People with this subtype have low numbers of red blood cells, and the cells have a specific mutation in their DNA.
Myelodysplastic syndromes with excess blasts. In this subtype, any of the three types of blood cells — red blood cells, white blood cells or platelets — might be low and appear abnormal under a microscope. Very immature blood cells (blasts) are found in the blood and bone marrow.
Myelodysplastic syndromes, unclassifiable. In this subtype, there are reduced numbers of one or more types of mature blood cells and the cells might look abnormal under the microscope. Sometimes the blood cells appear normal, but analysis might find that the cells have DNA changes that are associated with myelodysplastic syndromes.

Risk factors

Factors that can increase your risk of myelodysplastic syndromes include:

Older age. Most people with myelodysplastic syndromes are older than 60.
Previous treatment with chemotherapy or radiation. Chemotherapy or radiation therapy, both of which are commonly used to treat cancer, can increase your risk of myelodysplastic syndromes.
Exposure to certain chemicals. Chemicals, including benzene, have been linked to myelodysplastic syndromes.

Complications

Complications of myelodysplastic syndromes include:

Anemia. Reduced numbers of red blood cells can cause anemia, which can make you feel tired.
Recurrent infections. Having too few white blood cells increases your risk of serious infections.
Bleeding that won't stop. Lacking platelets in your blood to stop bleeding can lead to excessive bleeding.
Increased risk of cancer. Some people with myelodysplastic syndromes might eventually develop a cancer of the bone marrow and blood cells (leukemia).

Diagnosis

A physical exam, medical history and tests might be used if your doctor suspects that you have a myelodysplastic syndrome.

Tests might include:

Blood tests. Your doctor might order blood tests to determine the number of red cells, white cells and platelets and look for unusual changes in the size, shape and appearance of various blood cells.
Removing bone marrow for testing. During a bone marrow biopsy and aspiration, a thin needle is used to withdraw (aspirate) a small amount of liquid bone marrow, usually from a spot on the back of your hipbone. Then a small piece of bone with its marrow is removed (biopsy).

Blood and bone marrow samples are sent for laboratory analysis. Specialized tests can determine the specific characteristics of your cells that will be helpful for determining the type of myelodysplastic syndrome you have, your prognosis and your treatment options.

Treatment

Management of myelodysplastic syndromes is most often intended to slow the disease, ease symptoms and prevent complications. There's no cure for myelodysplastic syndromes, but some medications can help slow the progression of the disease.

If you have no symptoms, treatment might not be needed right away. Instead, your doctor might recommend regular exams and lab tests to monitor your condition and to see if the disease progresses.

Research on myelodysplastic syndromes is ongoing. Ask your doctor about clinical trials for which you might be eligible.

Blood transfusions

Blood transfusions with healthy blood cells from donors can be used to replace red blood cells and platelets in people with myelodysplastic syndromes. Blood transfusions can help control symptoms.

Medications

Treatment for myelodysplastic syndromes might include medications that:

Increase the number of blood cells your body makes. Called growth factors, these medications are artificial versions of substances found naturally in your bone marrow. Growth factors that stimulate your bone marrow to make more red blood cells can help reduce your need for frequent blood transfusions. Growth factors that promote white blood cell production may reduce your risk of infection.
Stimulate blood cells to mature. Medications that help stimulate the blood cells to mature can reduce the need for frequent blood transfusions in people who aren't helped by growth factors. Some of these drugs may also reduce the risk that the disease may progress to leukemia.
Suppress your immune system. Medications that suppress or control your immune system are used in certain myelodysplastic syndromes to reduce your need for red blood cell transfusions.
Help people with a certain genetic abnormality. If your myelodysplastic syndrome is associated with a gene mutation called isolated del(5q), your doctor might recommend lenalidomide (Revlimid).
Treat infections. If your condition causes you to have infections, you'll receive treatments to control them.

Bone marrow transplant

A bone marrow transplant, also known as a stem cell transplant, is the only treatment option that offers the potential of a cure for myelodysplastic syndromes. But this treatment carries a high risk of serious complications and it's generally reserved for people who are healthy enough to endure it.

During a bone marrow transplant, high doses of chemotherapy drugs are used to clear out the defective blood cells from your bone marrow. Then the abnormal bone marrow stem cells are replaced with healthy, donated cells (allogeneic transplant).

In some situations, less intense chemotherapy drugs can be used to reduce the risks of bone marrow transplant for older adults and those who might not otherwise be considered for this treatment.

Clinical trials

Explore Mayo Clinic studies testing new treatments, interventions and tests as a means to prevent, detect, treat or manage this condition.

Lifestyle and home remedies

Because people with certain myelodysplastic syndromes have low white blood cell counts, they're subject to recurrent, and often serious, infections.

To reduce your risk of infections:

Wash your hands. Wash hands frequently and thoroughly with warm, soapy water, especially before eating or preparing food. Carry an alcohol-based hand sanitizer for times when water isn't available.
Take care with food. Thoroughly cook all meat and fish. Avoid fruits and vegetables you can't peel, especially lettuce, and wash all produce you do use before peeling it. To increase safety, you might want to avoid all raw foods.
Avoid people who are ill. Try to avoid close contact with anyone who is sick, including family members and co-workers.

Preparing for your appointment

You'll likely start by seeing your family doctor or primary care doctor. If your doctor suspects that you have a myelodysplastic syndrome, you might be referred to a doctor who specializes in blood disorders (hematologist).

Here's some information to help you get ready for your appointment.

What you can do

When you make the appointment, ask if there's anything you need to do in advance, such as restrict your diet.

Make a list of:

Your symptoms, including those that seem unrelated to the reason for the appointment, and when they began
Key personal information, including previous treatment for cancer or exposure to toxic chemicals
All medications, vitamins and supplements you take, including doses
Questions to ask your doctor

Consider taking a family member or friend along to help you remember the information you're given.

For myelodysplastic syndromes, questions to ask your doctor might include:

What type of myelodysplastic syndrome do I have?
Will I need more tests?
What is my prognosis?
What is my risk of leukemia?
If I need treatment, what are my options and what do you recommend?
I have other health conditions. How can I best manage them together?
Are there restrictions I need to follow?
Are there brochures or other printed material that I can have? What websites do you recommend?

Don't hesitate to ask other questions.

What to expect from your doctor

Your doctor is likely to ask questions, such as:

Have your symptoms been continuous or occasional?
How severe are your symptoms?
What, if anything, seems to improve your symptoms?
What, if anything, appears to worsen your symptoms?